Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $10.8B |
| Sales growthchange from the year before | -0.5% |
| Gross marginshare of sales left after the direct cost of what it sells | 23.9% |
| Operating marginshare of sales left after running the business | 4.5% |
| Net marginshare of sales kept as profit | 3.4% |
| Free-cash-flow marginspare cash generated per $100 of sales | 5.7% |
| Return on invested capitalprofit made on each $100 put into the business | 3.7% |
| Return on equityprofit vs. shareholders' accounting value | 4.4% |
| Debt / equitydebt vs. shareholders' accounting value | 0.24 |
| Change in share countnegative = the company is buying back its shares | -1.9% |
3 insiders sold $8.7M on the open market.
| Lorberbaum Jeffrey SChief Executive Officer · Director · 10% owner | SoldAug 3 | 59,078 shat $131.59 · $7.8M |
| Helen Suzanne LOther | SoldAug 3 | 7,000 shat $131.52 · $921K |
| Repp David LeeSvp-Cao & Corporate Controller | SoldAug 3 | 225 shat $130.59 · $29K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy